MAGNESIUM SULFATE ANHYDROUS | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

MAGNESIUM SULFATE ANHYDROUS
US Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

MAGNESIUM SULFATE ANHYDROUS

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 12 USDMF, 4 JDMF, 4 NDC API, 5 Listed Suppliers, $ API Reference Price

16 API Suppliers
12 USDMF
4 JDMF
4 NDC API
5 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

106 FDF Dossiers, 66 FDA Orange Book, 14 Europe, 8 Canada, 5 South Africa, 13 Listed Dossiers

106 FDF Dossiers
66 FDA Orange Book
14 Europe
8 Canada
5 South Africa
13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 10GM/20ML (500MG/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 1GM/2ML (500MG/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 25GM/50ML (500MG/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 5GM/10ML (500MG/ML), EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML), EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML), EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML), EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML), EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (1540ML), EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2053ML), EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2566ML), POWDER;ORAL - 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT, TABLET;ORAL - 0.225GM;0.188GM;1.479GM

SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 10GM/20ML (500MG/ML)
SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 1GM/2ML (500MG/ML)
SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 25GM/50ML (500MG/ML)
SOLUTION;INTRAMUSCULAR, INTRAVENOUS - 5GM/10ML (500MG/ML)
EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML)
EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML)
EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML)
EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML)
EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (1540ML)
EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2053ML)
EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2566ML)
POWDER;ORAL - 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT
TABLET;ORAL - 0.225GM;0.188GM;1.479GM

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 7 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 8 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 BASF, 1 Bioplus Life Sciences, 1 BioSpectra, 10 Corel Pharma Chem, 2 DFE Pharma, 3 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 The Dow Chemical Company, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 32 Fillers, Diluents & Binders, 22 Controlled & Modified Release, 20 Thickeners and Stabilizers, 18 Parenteral, 18 Direct Compression, 14 Co-Processed Excipients, 13 Solubilizers, 11 Lubricants & Glidants, 10 Film Formers & Plasticizers, 9 Empty Capsules, 9 Granulation, 8 Taste Masking, 8 Emulsifying Agents, 6 Disintegrants & Superdisintegrants, 5 API Stability Enhancers, 5 Topical, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Chewable & Orodispersible Aids, 3 Rheology Modifiers, 2 Surfactant & Foaming Agents

45 Coating Systems & Additives
32 Fillers, Diluents & Binders
22 Controlled & Modified Release
20 Thickeners and Stabilizers
18 Parenteral
18 Direct Compression
14 Co-Processed Excipients
13 Solubilizers
11 Lubricants & Glidants
10 Film Formers & Plasticizers
9 Empty Capsules
9 Granulation
8 Taste Masking
8 Emulsifying Agents
6 Disintegrants & Superdisintegrants
5 API Stability Enhancers
5 Topical
4 Vegetarian Capsules
4 Coloring Agents
3 Chewable & Orodispersible Aids
3 Rheology Modifiers
2 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 44 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
44 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 10 Finished Drug Prices

2 US Medicaid Prescriptions
10 Finished Drug Prices

MARKET PLACE

15 APIs, 6 FDF Dossiers, 1 EXCIPIENTS

15 APIs
6 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

4 US Patents, 1 US Exclusivities

4 US Patents
1 US Exclusivities

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

$ API Ref.Price (USD/KG) : 34 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4BRAINTREE LABS

filter Patent Number Reset all filters

4 All

01 110143656

02 111033498

03 111382864

04 111638697

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 2Y

02 2Blank

filter Expiration Date Reset all filters

4 All

01 42037-08-04

Product Main Page

01

BRAINTREE LABS

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

2024 ACI Convention

Not Confirmed

BRAINTREE LABS

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-08-04

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 11382864

Drug Substance Claim :

Drug Product Claim :

Application Number : 213135

Patent Use Code : U-3164

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-08-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BRAINTREE LABS

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

2024 ACI Convention

Not Confirmed

BRAINTREE LABS

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-08-04

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 11033498

Drug Substance Claim :

Drug Product Claim :

Application Number : 213135

Patent Use Code : U-3164

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-08-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BRAINTREE LABS

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

2024 ACI Convention

Not Confirmed

BRAINTREE LABS

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-08-04

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 11638697

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213135

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-08-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BRAINTREE LABS

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

2024 ACI Convention

Not Confirmed

BRAINTREE LABS

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-08-04

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

US Patent Number : 10143656

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213135

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-08-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?